Morning Industry Symposium:
Identifying the right patients for chemotherapy in ER+ HER2- breast cancer
Supported by Genomic Health
Friday, September 6, 2019
06:45-08:00
Hall B
| 06:45-08:00 | Morning Industry Symposium: Identifying the right patients for chemotherapy in ER+ HER2- breast cancer Supported by Genomic Health |
| Chairperson | Christy A. Russell, USA |
| 07:00-07:30 | Treatment decision-making for young patients in light of new evidence from TAILORx Tiffany Traina, USA |
| 07:30-08:00 | Should all women with breast cancer and positive lymph nodes receive chemotherapy? Christy A. Russell, USA |